Singapore's Enhanced Multidisciplinary Strategy for Sarcoma Care

Strengthening Sarcoma Care in Singapore

Singapore is embarking on significant advancements in sarcoma care, focusing on a coordinated multidisciplinary approach to enhance diagnosis, referrals, and patient outcomes for this rare group of cancers. Sarcomas, which include various bone and soft tissue tumors, primarily impact adolescents and young adults. The fight against this disease requires a robust and integrated healthcare strategy that combines expertise from various specialties.

The Challenge of Sarcoma

Often, sarcomas present as painless lumps, leading to misdiagnosis and delayed treatment. While these tumors account for less than one percent of adult cancers, they constitute about 21 percent of pediatric cancers. The rarity of sarcomas means that many healthcare providers encounter these cases infrequently, which can hinder early identification. To tackle this problem, Singaporean healthcare institutions, including the National University Cancer Institute, Singapore (NCIS) and National Cancer Centre Singapore (NCCS), are now collaborating more closely than ever.

A Multidisciplinary Approach

The new initiative brings together specialists in surgery, medical oncology, radiation oncology, pathology, imaging, and allied health. The team shares a commitment to develop better clinical guidelines, ensuring that all patients receive comprehensive care tailored to their specific needs. An example of this extensive care is Mr. Terence Goh, who underwent a complex treatment journey after being diagnosed with retroperitoneal pleomorphic sarcoma. His experience highlights how coordinated care can effectively address the intricacies of sarcoma treatment.

Mr. Goh received neoadjuvant radiotherapy before undergoing surgery, which involved multiple organs and required careful perioperative planning. His treatment process was lengthy and complex, but he was supported by an integrated team at NCIS, allowing for ongoing assessment and adjustment of his therapies. Mr. Goh emphasizes the importance of trust in his medical team, stating, "What keeps me going is trusting the doctors and doing my best to live as normally as possible."

Heightened Awareness and Expert Guidance

The initiative also aims to strengthen awareness about sarcoma among clinicians. With many providers lacking experience in this area, uncertainty surrounding identification and referral can negatively impact patient outcomes. To address this, clinical experts are developing comprehensive, multidisciplinary guidance, including a new clinical handbook titled Clinical Management of Bone and Soft Tissue Tumours. This resource will aid healthcare professionals in navigating complex diagnostic pathways and will delineate when specialist referrals are necessary.

Empowering Patients

Patient experiences play a critical role in shaping this initiative. Hilman Basri, who was diagnosed with clear cell sarcoma at a young age, demonstrates resilience and advocacy for greater awareness in the community. Despite ongoing challenges, he engages with the healthcare system for long-term follow-up and rehabilitation. He participates in activities such as the Run For Hope Marathon, which symbolizes his fight and dedication to living fully while navigating his diagnosis.

Mr. Basri remarks, "This is not a death sentence. It is not the end, but the beginning of a new chapter." His determination and proactive collaboration with his medical team exemplify the patient-centric ethos of this multidisciplinary approach.

Looking Ahead

As Singapore continues to strengthen its sarcoma care framework, the focus will remain on enhancing early identification and streamlining referral processes. This new initiative aspires to not only improve clinical outcomes but to foster a support system that recognizes the importance of continuous research, community awareness, and holistic patient care. Ultimately, the goal is to ensure that every individual affected by sarcoma receives timely and effective treatment in a supportive environment.

Through these efforts, Singapore is setting an important precedent for how we approach complex cancers, acknowledging the need for collaboration and expert guidance in tackling these challenging medical conditions.